Comments to FDA: Drug Watch for Emerging Drug Safety Information

Share page:
Docket Number:
2005D-0062

CHPA has supported and continues to support the timely provision of complete and accurate product information to healthcare professionals and patients in an easily accessible format, and commends the Agency for considering new approaches to disseminating emerging drug safety-related data.

Related Posts

CHPA Statement on Valisure Citizen Petition